Skip to main content Back to Top
Advertisement

10/5/2020

Famotidine Injection

Products Affected - Description

    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 2 mL vial, 25 count, NDC 63323-0739-12
    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 20 mL vial, 10 count, NDC 63323-0738-20
    • Famotidine solution for injection, Hikma, 10 mg/mL, 2 mL vial, 25 count, NDC 00641-6022-25
    • Famotidine solution for injection, Hikma, 10 mg/mL, 20 mL vial, 10 count, NDC 00641-6021-10
    • Famotidine solution for injection, Hikma, 10 mg/mL, 4 mL vial, 25 count, NDC 00641-6023-25

Reason for the Shortage

    • Baxter had famotidine injection on shortage due to manufacturing delays.
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.

Available Products

    • Famotidine solution for injection, Baxter, 20 mg, 50 mL premixed bag, 12 count, NDC 00338-5197-41
    • Famotidine solution for injection, Fresenius Kabi, 10 mg/mL, 4 mL vial, 10 count, NDC 63323-0738-04
    • Famotidine solution for injection, Mylan Institutional, 10 mg/mL, 2 mL vial, 25 count, NDC 67457-0433-22
    • Famotidine solution for injection, Mylan Institutional, 10 mg/mL, 20 mL vial, 10 count, NDC 67457-0457-20
    • Famotidine solution for injection, Mylan Institutional, 10 mg/mL, 4 mL vial, 10 count, NDC 67457-0448-43

Estimated Resupply Dates

    • Fresenius Kabi has famotidine 10 mg/mL 2 mL and 20 mL vials on back order and the company estimates a release date of mid-to late-October 2020 for the 2 mL vials and 4th quarter 2020 for the 20 mL vials.
    • Hikma has famotidine 10 mg/mL 4 mL vials on back order and the company cannot estimate a release date. The 2 mL and 20 mL vials are on back order and the company estimates a release date of early-October 2020.

Updated

Updated October 5, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 30, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.